References:
General Hematology/Oncology
- Moss, J et al. Central Venous Access Devices for the Delivery of Systemic Anticancer Therapy (CAVA): A Randomised Controlled Trial. Lancet 2021.
- Open-label, multi-center randomized controlled trial of 1,061 adult patients receiving systemic anticancer treatment (SACT) for solid or hematological malignancy via PICCs vs Hickman vs Ports. The median dwell time of ports (over 350 days) was much greater than Hickman (around 160 days) and PICCs (around 120 days).
- Skummer, P. et al. Risk Factors for Early Port Infections in Adult Oncologic Patients. J Vasc Interv Radiol 2020.
- Retrospective study of 1,714 patients who underwent port placements. A total of 20 patients (1.2%) had early port infections; 15 patients (0.9%) had positive blood cultures. The mean time to infection was 20 days (range, 9-30 days). The port-related 30-day mortality rate was 0.2% (4 of 1,714 patients).